Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rey-Heng Hu

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 30, 2015
First Case Genotype 4 Hepatitis E Infection After a Liver TransplantChien-Hui Wu, Cheng-Maw Ho, Jia-Huei Tsai, et al.
Clinical Transplantation|November 19, 2009
Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipientCheng-Maw Ho, Shiu-Feng Huang, Rey-Heng Hu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 16, 2022
Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinomaChih-Horng Wu, Yu-Hsin Lee, Po-Chin Liang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 18, 2008
Favorable results of concomitant tacrolimus and sirolimus therapy in Taiwanese renal transplant recipients at 12 monthsKuo-Hsin Chen, Meng-Kun Tsai, I-Rue Lai, et al.
The International Journal of Artificial Organs|August 12, 2009
Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapyMeng-Kun Tsai, Fe-Lin Lin Wu, I-Rue Lai, et al.
Hepatology International|September 10, 2010
Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary centerYa-Wen Yang, Che-Hsiung Wu, Rey-Heng Hu, et al.
Annals of Surgical Oncology|March 19, 2013
Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinomaCheng-Maw Ho, Chao-Ying Wu, Po-Huang Lee, et al.
Cancer Research|July 9, 2013
C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerizationYao-Ming Wu, Chiung-Hui Liu, Miao-Juei Huang, et al.
Medicine|October 28, 2016
Abuse-related trauma forward medical care in a randomly sampled nationwide populationCheng-Maw Ho, Chih-Hsin Lee, Jann-Yuan Wang, et al.
BMC Cancer|April 11, 2018
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort studyCheng-Maw Ho, Chih-Hsin Lee, Ming-Chia Lee, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 30, 2015
First Case Genotype 4 Hepatitis E Infection After a Liver TransplantChien-Hui Wu, Cheng-Maw Ho, Jia-Huei Tsai, et al.
Clinical Transplantation|November 19, 2009
Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipientCheng-Maw Ho, Shiu-Feng Huang, Rey-Heng Hu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 16, 2022
Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinomaChih-Horng Wu, Yu-Hsin Lee, Po-Chin Liang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 18, 2008
Favorable results of concomitant tacrolimus and sirolimus therapy in Taiwanese renal transplant recipients at 12 monthsKuo-Hsin Chen, Meng-Kun Tsai, I-Rue Lai, et al.
The International Journal of Artificial Organs|August 12, 2009
Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapyMeng-Kun Tsai, Fe-Lin Lin Wu, I-Rue Lai, et al.
Hepatology International|September 10, 2010
Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary centerYa-Wen Yang, Che-Hsiung Wu, Rey-Heng Hu, et al.
Annals of Surgical Oncology|March 19, 2013
Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinomaCheng-Maw Ho, Chao-Ying Wu, Po-Huang Lee, et al.
Cancer Research|July 9, 2013
C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerizationYao-Ming Wu, Chiung-Hui Liu, Miao-Juei Huang, et al.
Medicine|October 28, 2016
Abuse-related trauma forward medical care in a randomly sampled nationwide populationCheng-Maw Ho, Chih-Hsin Lee, Jann-Yuan Wang, et al.
BMC Cancer|April 11, 2018
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort studyCheng-Maw Ho, Chih-Hsin Lee, Ming-Chia Lee, et al.
Pageof 14